tiprankstipranks
Nova Eye Medical (DE:E6M)
BERLIN:E6M

Nova Eye Medical (E6M) Stock Price & Analysis

0 Followers

E6M Stock Chart & Stats

Day’s Range€0 - €0
52-Week Range€0.06 - €0.18
Previous Close€0.13
Volume0.00
Average Volume (3M)N/A
Market Cap
€31.01M
Enterprise Value€27.36M
Total Cash (Recent Filing)AU$8.00M
Total Debt (Recent Filing)AU$1.94M
Price to Earnings (P/E)N/A
Beta-0.25
Aug 28, 2024
EPS EstimateN/A
Expense RatioN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding228,797,274
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard Deviation0.20
R-Squared0.05
Alpha0.10
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

E6M FAQ

What was Nova Eye Medical’s price range in the past 12 months?
Nova Eye Medical lowest stock price was €0.06 and its highest was €0.18 in the past 12 months.
    What is Nova Eye Medical’s market cap?
    Currently, no data Available
    When is Nova Eye Medical’s upcoming earnings report date?
    Nova Eye Medical’s upcoming earnings report date is Aug 28, 2024 which is in 153 days.
      How were Nova Eye Medical’s earnings last quarter?
      Nova Eye Medical released its earnings results on Feb 22, 2024. The company reported -€0.018 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.018.
        Is Nova Eye Medical overvalued?
        According to Wall Street analysts Nova Eye Medical’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Nova Eye Medical pay dividends?
          Nova Eye Medical pays a Notavailable dividend of €0.08 which represents an annual dividend yield of N/A. See more information on Nova Eye Medical dividends here
            What is Nova Eye Medical’s EPS estimate?
            Nova Eye Medical’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Nova Eye Medical have?
            Currently, no data Available
            What happened to Nova Eye Medical’s price movement after its last earnings report?
            Nova Eye Medical reported an EPS of -€0.018 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of Nova Eye Medical?
              Currently, no hedge funds are holding shares in DE:E6M
              ---

              Company Description

              Nova Eye Medical

              Ellex Medical Lasers Ltd. engages in design and manufacture of ophthalmic laser and ultrasound systems used by ophthalmologists to diagnose and treat eye diseases. It operates through the following segments: Faster Growing (iTrack), Emerging (2RT), and Core Ophthalmic Mark (Lasers and Ultrasounds). The iTrack segment offers catheter device that dilates the ocular structures compromised by glaucoma. The 2RT segment includes patent-protected with significant lead on competition and a per-use recurring fee business model. The Lasers and Ultrasounds segment represents testimony to the strength of the Ellex brand and was driven by growth in sales of the high-margin Ellex Tango and Ellex Tango Reflex glaucoma lasers. The company was founded by Giuseppe Canala and Victor Previn in 1985 and is headquartered in Adelaide, Australia.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Nova Eye Medical
              Novartis
              Bristol-Myers Squibb
              Amgen
              Eli Lilly & Co
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis